cemdisiran (ALN-CC5) - Alnylam, Regeneron
PiaSky (crovalimab) - Roche
Coversin SC (nomacopan SC) - Akari Therap
Veopoz (pozelimab-bbfg) - Regeneron
Fabhalta (iptacopan) - Novartis
tesidolumab (LFG316) - Novartis, MorphoSys
Soliris (eculizumab) - AstraZeneca
Ultomiris (ravulizumab-cwvz) - AstraZeneca
Empaveli (pegcetacoplan SC) - Apellis, SOBI
Zilbrysq (zilucoplan) - UCB
Voydeya (danicopan) - AstraZeneca
http://www.ncbi.nlm.nih.gov/pubmed/38622956
 
Bruno Fattizzo; Francesco Versino
 
Apr 16, 2024
 
Prev Next